Late Breaking Abstract - COVID 19 severity is associated with the presence of lung derived cfDNA in plasma
A. Rokach (Jerusalem, Israel), R. Ben Ami (Jerusalem, Israel), E. Cohen (Jerusalem, Israel), N. Bogot (Jerusalem, Israel), D. Kochan (Jerusalem, Israel), G. Kalak (Jerusalem, Israel), A. Jarjoui (Jerusalem, Israel), C. Chen Shuali (Jerusalem, Israel), H. Azulai (Jerusalem, Israel), H. Barhoum (Jerusalem, Israel), M. Greenberg (Jerusalem, Israel), D. Velleman (Jerusalem, Israel), R. Kurd (Jerusalem, Israel), E. Ben Chetrit (Jerusalem, Israel), A. Quteineh (Jerusalem, Israel), Y. Dor (Jerusalem, Israel)
Source: International Congress 2022 – Contribution of host-microbe interactions to respiratory disease
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Rokach (Jerusalem, Israel), R. Ben Ami (Jerusalem, Israel), E. Cohen (Jerusalem, Israel), N. Bogot (Jerusalem, Israel), D. Kochan (Jerusalem, Israel), G. Kalak (Jerusalem, Israel), A. Jarjoui (Jerusalem, Israel), C. Chen Shuali (Jerusalem, Israel), H. Azulai (Jerusalem, Israel), H. Barhoum (Jerusalem, Israel), M. Greenberg (Jerusalem, Israel), D. Velleman (Jerusalem, Israel), R. Kurd (Jerusalem, Israel), E. Ben Chetrit (Jerusalem, Israel), A. Quteineh (Jerusalem, Israel), Y. Dor (Jerusalem, Israel). Late Breaking Abstract - COVID 19 severity is associated with the presence of lung derived cfDNA in plasma. 1303
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|